[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-361331-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-361331-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tumor-biomarkers-in-head-and-neck-squamous-cell-carcinoma-a-scoping-review","Tumor Biomarkers in Head and Neck Squamous Cell Carcinoma - A Scoping Review","","Currently, head and neck squamous cell carcinoma (HNSCC) shows rising global incidence, with many diagnoses occurring at advanced stages. Conventional treatments are linked to poor quality of life, while aggressive tumor biology drives recurrence in about half of treated patients. To support rapid, targeted and personalized care, this scoping review maps tumor biomarkers with diagnostic, prognostic and predictive value for treatment response. Biomarkers are categorized by genomic, proteomic, cytokine, tumor microenvironment, metabolic and microbiota-associated features, and evidence for roles in carcinogenesis, response and therapy resistance is summarized. Although few biomarkers are routine in clinical practice, the review highlights promising candidates and emphasizes validation and methodological standardization for future personalized multimodal strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tumor-biomarkers-in-head-and-neck-squamous-cell-carcinoma-a-scoping-review/361331/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tumor-biomarkers-in-head-and-neck-squamous-cell-carcinoma-a-scoping-review/361331.png","ImageObject",300,407,{"name":42,"@type":43},"mieayamfan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is there an increasing need for tumor biomarkers in HNSCC?","Question",{"text":63,"@type":64},"HNSCC incidence continues to rise and many cases are diagnosed at advanced stages. Poor quality of life from conventional treatments and high recurrence rates make targeted diagnosis and personalized treatment more urgent.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the scoping review categorize tumor biomarkers?",{"text":68,"@type":64},"It classifies biomarkers according to genomic, proteomic, cytokine-related, tumor microenvironment, metabolic, and microbiota-associated characteristics, and considers overlapping functional roles.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the review say about clinical use of biomarkers today?",{"text":72,"@type":64},"Only a limited number of biomarkers are implemented in routine clinical practice for head and neck cancers. The review identifies promising candidates that may be incorporated after prospective validation and methodological standardization.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},361331,1791061960,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Review  \nTumor Biomarkers in Head and Neck Squamous Cell Carcinoma: From Etiology and Pathogenesis to Treatment Response—A Scoping Review  \nCosmina-Diana Drăgan 1,2, *, Alexandra-Maria Marin 1,2, Oana Cezara Frasina-Vlad 3, Luminia Măruescu 3, Petronela Ancua 3,4,5, Anca Ionela Cîrstea 1,6, Mihai Dumitru Tudosie 1,2, Alexandru Nicolaescu 1,7, Catrinel Beatrice Simion-Antonie 1, Simona Andreea Rujan 1,2, Bianca Petra Taher 1,2, Daniel Voiculescu 1,8,¸Serban Vifor Gabriel Berte¸steanu 1,2 and Raluca Grigore 1,2, *  \nAcademic Editor: John K. Triantafillidis  \nReceived: 11 July 2026  \nRevised: 10 August 2026  \nAccepted: 13 August 2026  \nPublished: 16 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania; [alexandra-maria.marin@drd.umfcd.ro](alexandra-maria.marin@drd.umfcd.ro) (A.-M.M.); [anca-ionela.cirstea@drd.umfcd.ro](anca-ionela.cirstea@drd.umfcd.ro) (A.I.C.); [mihai-dumitru.tudosie@drd.umfcd.ro](mihai-dumitru.tudosie@drd.umfcd.ro) (M.D.T.); [alexandru.nicolaescu@umfcd.ro](alexandru.nicolaescu@umfcd.ro) (A.N.); [catrinel.simion-antonie@drd.umfcd.ro](catrinel.simion-antonie@drd.umfcd.ro) (C.B.S.-A.); [simona-andreea.rujan@drd.umfcd.ro](simona-andreea.rujan@drd.umfcd.ro) (S.A.R.); [bianca-petra.taher@drd.umfcd.ro](bianca-petra.taher@drd.umfcd.ro) (B.P.T.); [daniel.voiculescu@umfcd.ro](daniel.voiculescu@umfcd.ro) (D.V.); [serban.bertesteanu@umfcd.ro](serban.bertesteanu@umfcd.ro) ( ¸S.V.G.B.)  \n2 Department of ENT, Head and Neck Surgery, Col¸tea Clinical Hospital, 030171 Bucharest, Romania  \n3 Faculty of Biology, University of Bucharest, 050663 Bucharest, Romania; [vlad.oana18@gmail.com](vlad.oana18@gmail.com) (O.C.F.-V.); [luminita.marutescu@bio.unibuc.ro](luminita.marutescu@bio.unibuc.ro) (L.M.)  \n4 Department of Microbiology, Infectious Diseases and Immunology, Faculty of Medicine, Université de Montréal, Montréal, QC H3C 3J7, Canada  \n5 Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, QC H2X 0A9, Canada  \n6 Department of ENT, Head and Neck Surgery, Emergency University Hospital, 021373 Bucharest, Romania  \n7 Department of ENT, Prof. Dr. Dimitrie Gerota Emergency Hospital, 021373 Bucharest, Romania  \n8 Department of Surgery I, Emergency University Hospital, 021373 Bucharest, Romania  \n* Correspondence: [cosmina-diana.dragan@drd.umfcd.ro](cosmina-diana.dragan@drd.umfcd.ro) (C.-D.D.); [raluca.grigore@umfcd.ro](raluca.grigore@umfcd.ro) (R.G.); Tel.: +40-725887300 (C.-D.D.)  \nAbstract  \nCurrently, the global incidence of head and neck squamous cell carcinoma (HNSCC) continues to increase, with a large proportion of cases being diagnosed at advanced stages. Conventional oncological treatments are often associated with poor quality of life, while the aggressive biological behavior of these tumors results in recurrence in approximately half of treated patients according to current evidence. The need for rapid, targeted diagnosis and personalized treatment has driven research toward the identification of tumor biomarkers with diagnostic, prognostic, and predictive value for treatment response. In this scoping review, we performed a comprehensive literature search to map the available evidence on tumor biomarkers in HNSCC. We identified a wide range of biomarkers, several of which exhibit overlapping roles, and classified them according to their genomic, proteomic, cytokine-related, tumor microenvironment, metabolic, and microbiota-associated characteristics. This scoping review also summarizes the current evidence regarding biomarkers involved in carcinogenesis, treatment response and therapy resistance, while highlighting their current level of clinical applicability. Although only a limited number of biomarkers have currently been im","cbCairnzECEucQ8l","https://ap.wps.com/l/cbCairnzECEucQ8l","pdf",529840,35,"English","# Abstract\n# Introduction\n# Biomarkers and Evidence Mapping\n# Clinical Applicability and Future Directions","[{\"question\":\"Why is there an increasing need for tumor biomarkers in HNSCC?\",\"answer\":\"HNSCC incidence continues to rise and many cases are diagnosed at advanced stages. Poor quality of life from conventional treatments and high recurrence rates make targeted diagnosis and personalized treatment more urgent.\"},{\"question\":\"How does the scoping review categorize tumor biomarkers?\",\"answer\":\"It classifies biomarkers according to genomic, proteomic, cytokine-related, tumor microenvironment, metabolic, and microbiota-associated characteristics, and considers overlapping functional roles.\"},{\"question\":\"What does the review say about clinical use of biomarkers today?\",\"answer\":\"Only a limited number of biomarkers are implemented in routine clinical practice for head and neck cancers. The review identifies promising candidates that may be incorporated after prospective validation and methodological standardization.\"}]","Tumor Biomarkers in Head and Neck Squamous Cell Carcinoma - A Scoping Review | PDF",1790143956,88,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7c40ee7f0d0293a05fc19f3903049d6.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03e8796ec6cb8f8c44cd7c45666d7e79.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3cb1a4ad1fdd1b8d2857d12f7f125ee.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/310c09d8bda84c2580869bec974e2538.webp",980,1385]